Relevate Health (PRIVATE.RELEVATE)

Overall impact
D (37)

Commentary

Relevate Health is a below-average overall performer. With a 'D' rating of 37.0 for overall impact (bottom 25% of all companies), Relevate Health ranks 43rd out of 48 industry peers, behind Kantar Media, BlueCrest, Adevinta and 39 others, and ahead of Ion Analytics, Binyan Studios, Internet Brands and 2 others. On top material causes for Relevate Health's industry (Interactive Media & Services), Relevate Health performs well in Technology Innovation (94.7 score) and performs poorly in Sustainable Use of Natural Resources (39.0 score), Reduced Inequality (21.9), Arts and Culture Access (12.7) and 9 other causes where it received a 'D' or 'F' score.
Impact
Cause PRIVATE.RELEVATE
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
200
Sector
Communication Services
Industry
Interactive Media & Services
Sub-industry
Interactive Media & Services
SASB industry
Internet Media & Services
Headquarters
#<Country/State:0x0000fffece593350>, United States
Share classes
PRIVATE.RELEVATE
Description
Provider of data-driven marketing services intended to serve pharmaceutical companies, biotechnology companies, eye care providers, and hospitals. The company specializes in data analytics, marketing campaigns, audience targeting, digital outreach, and marketing strategy, thereby enabling healthcare providers and patients to receive targeted information and communication.
Material causes
Ethos considers the following causes material for Relevate Health, based on its industry sub-industry Interactive Media & Services. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.